...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO-Europe 11/7
Reply New Message
Prev Message Back To Forum Threaded View Next Message

It wouldn't surprise me if they were not in the office yet in Calgary. I would give it an hour and a half from now before getting to excited.

tada

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply